We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$531M
AUM Growth
+$42.3M
Cap. Flow
+$686K
Cap. Flow %
0.13%
Top 10 Hldgs %
66.25%
Holding
96
New
3
Increased
15
Reduced
52
Closed
5

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$4.92M
2
WBA
Walgreens Boots Alliance
WBA
+$4.48M
3
AMGN icon
Amgen
AMGN
+$3.78M
4
INTC icon
Intel
INTC
+$3.76M
5
CVX icon
Chevron
CVX
+$2.77M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$4.65M
2
RKT icon
Rocket Companies
RKT
+$3.85M
3
BABA icon
Alibaba
BABA
+$2.91M
4
QCOM icon
Qualcomm
QCOM
+$2.7M
5
XOM icon
ExxonMobil
XOM
+$2.58M

Sector Composition

Rank Sector Weight
1 Financials 40.09%
2 Healthcare 18.68%
3 Technology 12.74%
4 Energy 11.58%
5 Consumer Staples 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTGC icon
51
Hercules Capital
HTGC
$3.3B
$827K 0.16%
49,824
-176
-0.4% -$2.98K
MTB icon
52
M&T Bank
MTB
$34.9B
$802K 0.15%
5,225
TXN icon
53
Texas Instruments
TXN
$239B
$773K 0.15%
4,100
PLTR icon
54
Palantir
PLTR
$424B
$747K 0.14%
41,042
-1,702
-4% -$37.6K
BBL
55
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$737K 0.14%
12,324
-401
-3% -$21.9K
ABT icon
56
Abbott
ABT
$199B
$709K 0.13%
5,040
MCD icon
57
McDonald's
MCD
$188B
$594K 0.11%
2,215
GSK icon
58
GSK
GSK
$103B
$592K 0.11%
+10,740
New +$559K
ITW icon
59
Illinois Tool Works
ITW
$81.1B
$591K 0.11%
2,395
SWKS icon
60
Skyworks Solutions
SWKS
$9.87B
$589K 0.11%
3,799
-130
-3% -$20.8K
IFF icon
61
International Flavors & Fragrances
IFF
$22.3B
$581K 0.11%
3,855
-50
-1% -$7.28K
TSM icon
62
TSMC
TSM
$2.17T
$561K 0.11%
4,660
-450
-9% -$52.7K
SYF icon
63
Synchrony
SYF
$26B
$538K 0.1%
11,605
PHM icon
64
Pultegroup
PHM
$24.9B
$491K 0.09%
8,585
-275
-3% -$14.1K
SO icon
65
Southern Company
SO
$103B
$471K 0.09%
6,875
DHI icon
66
D.R. Horton
DHI
$42B
$466K 0.09%
4,300
-300
-7% -$28.9K
PM icon
67
Philip Morris
PM
$303B
$458K 0.09%
4,825
-50
-1% -$4.67K
JAZZ icon
68
Jazz Pharmaceuticals
JAZZ
$16.3B
$445K 0.08%
3,494
+1,252
+56% +$165K
WFC icon
69
Wells Fargo
WFC
$258B
$416K 0.08%
8,670
-329
-4% -$16.2K
QSR icon
70
Restaurant Brands International
QSR
$27.8B
$412K 0.08%
6,786
-631
-9% -$37.2K
GD icon
71
General Dynamics
GD
$103B
$393K 0.07%
1,887
+128
+7% +$25.8K
LPX icon
72
Louisiana-Pacific
LPX
$5.03B
$392K 0.07%
4,998
-452
-8% -$31K
ZBH icon
73
Zimmer Biomet
ZBH
$19.3B
$391K 0.07%
3,167
MHK icon
74
Mohawk Industries
MHK
$8.97B
$350K 0.07%
1,923
CSX icon
75
CSX Corp
CSX
$96.5B
$340K 0.06%
9,030

Similar funds

Greylin Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Greylin Investment Management held 96 positions worth $531M, up 8.7% from $488M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Greylin Investment Management's Q4 2021 filing shows 3 new, 15 increased, 52 reduced and 5 closed positions. Its largest new stake was Viatris: 125,231 shares worth $1.69M. The largest sale was IBM, an estimated $4.65M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

  • Greylin Investment Management's largest Q4 2021 buy was Viatris: 125,231 shares worth $1.69M.
  • Greylin Investment Management added most to Cardinal Health in Q4 2021, an estimated $4.92M increase.
  • Greylin Investment Management's biggest Q4 2021 reduction was IBM, cutting an estimated $4.65M.
  • Greylin Investment Management fully exited StoneCo in Q4 2021, selling an estimated $1.13M.
  • Greylin Investment Management's ten largest holdings make up 66% of its $531M portfolio in Q4 2021.
  • Greylin Investment Management opened 3 new positions and closed 5 in Q4 2021.
  • Greylin Investment Management's portfolio value rose 8.7% quarter-over-quarter to $531M.

Based on Greylin Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.